115 related articles for article (PubMed ID: 17638612)
1. Metabolic and molecular imaging in neuro-oncology.
Herholz K; Coope D; Jackson A
Lancet Neurol; 2007 Aug; 6(8):711-24. PubMed ID: 17638612
[TBL] [Abstract][Full Text] [Related]
2. [German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids].
Langen KJ; Bartenstein P; Boecker H; Brust P; Coenen HH; Drzezga A; Grünwald F; Krause BJ; Kuwert T; Sabri O; Tatsch K; Weber WA; Schreckenberger M
Nuklearmedizin; 2011; 50(4):167-73. PubMed ID: 21789338
[TBL] [Abstract][Full Text] [Related]
3. Advances in neuro-oncology imaging.
Langen KJ; Galldiks N; Hattingen E; Shah NJ
Nat Rev Neurol; 2017 May; 13(5):279-289. PubMed ID: 28387340
[TBL] [Abstract][Full Text] [Related]
4. Anatomical and biochemical investigation of primary brain tumours.
Del Sole A; Falini A; Ravasi L; Ottobrini L; De Marchis D; Bombardieri E; Lucignani G
Eur J Nucl Med; 2001 Dec; 28(12):1851-72. PubMed ID: 11734927
[TBL] [Abstract][Full Text] [Related]
5. Neuroimaging in patients with gliomas.
Ullrich RT; Kracht LW; Jacobs AH
Semin Neurol; 2008 Sep; 28(4):484-94. PubMed ID: 18843576
[TBL] [Abstract][Full Text] [Related]
6. Update on amino acid PET of brain tumours.
Langen KJ; Galldiks N
Curr Opin Neurol; 2018 Aug; 31(4):354-361. PubMed ID: 29952832
[TBL] [Abstract][Full Text] [Related]
7. Progress in magnetic resonance imaging of brain tumours.
Lemort M; Canizares-Perez AC; Van der Stappen A; Kampouridis S
Curr Opin Oncol; 2007 Nov; 19(6):616-22. PubMed ID: 17906462
[TBL] [Abstract][Full Text] [Related]
8. [Functional imaging in brain tumors].
Borbély K
Orv Hetil; 2004 Feb; 145(8):411-23. PubMed ID: 15061026
[TBL] [Abstract][Full Text] [Related]
9. Validity of PET studies in brain tumors.
Herholz K; Wienhard K; Heiss WD
Cerebrovasc Brain Metab Rev; 1990; 2(3):240-65. PubMed ID: 2121212
[TBL] [Abstract][Full Text] [Related]
10. [Amino acid uptake in brain tumors using positron emission tomography as an indicator for evaluating metabolic activity and malignancy].
Schober O; Meyer GJ; Duden C; Lauenstein L; Niggemann J; Müller JA; Gaab MR; Becker H; Dietz H; Hundeshagen H
Rofo; 1987 Nov; 147(5):503-9. PubMed ID: 2825284
[TBL] [Abstract][Full Text] [Related]
11. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
12. Progress in neuro-imaging of brain tumors.
Castellano A; Falini A
Curr Opin Oncol; 2016 Nov; 28(6):484-493. PubMed ID: 27649026
[TBL] [Abstract][Full Text] [Related]
13. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of brain disorders and evaluation of therapy by functional and molecular magnetic resonance techniques.
Wang YX; Lam WW
Hong Kong Med J; 2008 Dec; 14(6):469-78. PubMed ID: 19060347
[TBL] [Abstract][Full Text] [Related]
15. Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.
Hutterer M; Hattingen E; Palm C; Proescholdt MA; Hau P
Neuro Oncol; 2015 Jun; 17(6):784-800. PubMed ID: 25543124
[TBL] [Abstract][Full Text] [Related]
16. Radiomics, Metabolic, and Molecular MRI for Brain Tumors.
Kickingereder P; Andronesi OC
Semin Neurol; 2018 Feb; 38(1):32-40. PubMed ID: 29548050
[TBL] [Abstract][Full Text] [Related]
17. Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.
Pirotte B; Goldman S; Massager N; David P; Wikler D; Lipszyc M; Salmon I; Brotchi J; Levivier M
J Neurosurg; 2004 Sep; 101(3):476-83. PubMed ID: 15352606
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intraoperative fluorescence and MRI image guided neuronavigation in malignant brain tumours, a prospective controlled study.
Eljamel S; Petersen M; Valentine R; Buist R; Goodman C; Moseley H; Eljamel S
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):356-61. PubMed ID: 24284085
[TBL] [Abstract][Full Text] [Related]
19. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
20. Image correlation in oncology.
Chen GT; Pelizzari CA; Levin DN
Important Adv Oncol; 1990; ():131-41. PubMed ID: 2182516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
